This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Lucas Harrington, PhD
Co-founder and Chief Scientific Officer at Mammoth Biosciences


As co-founder and CSO of Mammoth Biosciences, Lucas drives the translation of novel CRISPR discoveries into genetic cures. Lucas co-founded Mammoth Biosciences with Jennifer Doudna, Janice Chen, and Trevor Martin with the goal of leveraging novel CRISPR systems to provide permanent cures for genetic diseases and to democratize disease detection. Lucas conducted his undergraduate work at Washington University in St. Louis and Ph.D. at the University of California, Berkeley with Jennifer Doudna. Lucas is also a general partner for Scifounder Capital, a fund and incubator with the goal of helping more scientists start and build companies.

Agenda Sessions

  • Discovery and Engineering of Ultracompact CRISPR Proteins for Therapeutic Genome Editing